DNA Research Advance Access originally published online on March 11, 2008
DNA Research 2008 15(2):73-81; doi:10.1093/dnares/dsn002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enhanced Recombinant Protein Productivity by Genome Reduction in Bacillus subtilis



1 Biological Science Laboratories, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi 321-3497, Japan
2 Graduate School of Information Science, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma, Nara 630-0101, Japan
3 Department of Bioscience and Textile Technology, Interdisciplinary Graduate School of Science and Technology, Shinshu University, 3-15-1 Tokida, Ueda, Nagano 386-8567, Japan
4 Graduate School of Life and Environmental Sciences, Tsukuba University, 1-1-1 Ten-noudai, Tsukuba, Ibaraki 305-8572, Japan
Received 24 December 2007; accepted 17 January 2008.
| Abstract |
|---|
|
|
|---|
The emerging field of synthetic genomics is expected to facilitate the generation of microorganisms with the potential to achieve a sustainable society. One approach towards this goal is the reduction of microbial genomes by rationally designed deletions to create simplified cells with predictable behavior that act as a platform to build in various genetic systems for specific purposes. We report a novel Bacillus subtilis strain, MBG874, depleted of 874 kb (20%) of the genomic sequence. When compared with wild-type cells, the regulatory network of gene expression of the mutant strain is reorganized after entry into the transition state due to the synergistic effect of multiple deletions, and productivity of extracellular cellulase and protease from transformed plasmids harboring the corresponding genes is remarkably enhanced. To our knowledge, this is the first report demonstrating that genome reduction actually contributes to the creation of bacterial cells with a practical application in industry. Further systematic analysis of changes in the transcriptional regulatory network of MGB874 cells in relation to protein productivity should facilitate the generation of improved B. subtilis cells as hosts of industrial protein production.
Key words: Bacillus subtilis; genome size reduction; recombinant protein productivity
| 1. Introduction |
|---|
|
|
|---|
The emerging field of synthetic genomics is expected to facilitate the generation of microorganisms with the potential to achieve a sustainable society.1
In a previous study, Posfai et al.4
reported an E. coli strain, MDS42, in which
15% of the genome sequence (0.71 Mb) was removed by planned and sequential deletions to eliminate all mobile DNA and cryptic virulence genes. The resultant strain displayed normal cell growth and protein expression comparable with that of the parental strain, MG1655. Interestingly, genome reduction gave rise to unexpected beneficial properties. MDS42 cells exhibit high electroporation efficiency and allow the accurate propagation of plasmids that are unstable in other strains. Another E. coli strain, MGF-01, with a 22% genome size reduction (1.03 Mb) was created in Japan using a similar strategy.5
MGF-01 cells also displayed an unexpected phenotype in that growth was as rapid as the parental W3110 strain in M9 minimal medium during the exponential phase, but continued after the wild-type strain had progressed to the stationary phase. In addition, MGF-01 secreted twice the amount of threonine as the wild-type strain.
B. subtilis, one of the most extensively studied model microorganisms, displays superior ability to produce various secretary enzymes. This ability has been widely applied to produce various useful enzymes in the industrial field.8
The 4.2 Mb B. subtilis genome contains 10 horizontally acquired prophage (SPβ and PBSX) and prophage-like (pro1-7 and skin) sequences.9
In addition, 2.8% of the genome encompasses two large operons that produce secondary metabolites (pks and pps). Systematic inactivation of the protein-coding regions revealed that only 271 genes are indispensable for growth in rich medium (LB) at 37°C, as growth is impossible in the absence of these genes.10
Westers et al.7
reported a B. subtilis
6 mutant strain with a 7.7% reduction of the genome (0.53 Mb) produced by deleting two prophage (SPβ, PBSX), three prophage-like sequences (pro1, pro6, skin), and the pks operon. However, phenotypic characterization of the
6 cells disclosed no unique properties, including secretion of AmyQ protein, relative to wild-type 168 cells.7
Our group generated a strain, MGB469, in which all prophage and prophage-like sequences, except pro7, as well as pks and pps operons, were deleted.6
In this case, cell growth was normal, but no beneficial properties were apparent, including exogenous protein production from the plasmid harboring the corresponding genes. Moreover, we constructed the MG1M strain containing an additional six deletions in the MGB469 genome, resulting in a 0.99 Mb reduction in genome size.6
However, the MG1M strain displayed unstable phenotypes with regard to growth rate, cell morphology, and recombinant protein productivity after successive culture, making it inappropriate for further studies.
Here, we report the generation of another multiple-deletion series of mutants, from MGB469 as the starting strain through to MGB874 with a total 0.87 Mb genome deletion. When compared with wild-type cells, the regulatory network of gene expression of the mutant strain is reorganized after entry into the transition state due to the synergistic effect of multiple deletions, and productivity of extracellular cellulase and protease from transformed plasmids harboring the corresponding genes is remarkably enhanced. Our results demonstrate the effectiveness of synthetic genomics in creating novel and useful bacteria for industrial use.
| 2. Materials and Methods |
|---|
|
|
|---|
2.1. Culture media and measurement of enzyme activity
Spizizen's minimal medium (SMM)11
2.2 High-resolution transcriptome analysis
The custom Affymetrix tiling chip used contains 55 430 25-mer probes for the coding strand of protein coding regions at 25–30 bp intervals and 72 218 probes for both strands of intergenic regions at 2–3 bp intervals.15
Cultures (200 mL) of wild-type 168 and MGB874 cells (OD600 = 0.6) in 2xL-Mal at 30°C were inoculated into 15 L of 2xL-Mal medium within a 30 L jar fermenter. Total RNA was extracted from B. subtilis cells (10 OD600), as described previously.16
Synthesis of cDNA, terminal labeling, and oligonucleotide chip hybridization were performed following the Affymetrix instruction manual. Briefly, cDNA was synthesized from 10 µg total RNA using random primers and reverse transcriptase (Superscript III, Invitrogen), followed by purification using QiaQuick columns (Qiagen) and digestion with DNase I (GE Healthcare Bioscience). Next, cDNA fragments were terminally labeled with biotin-ddUTP using a ENZO BioArray Terminal Labeling Kit (Enzo Life Sciences). Hybridization with the oligonucleotide chip was performed for 16 h at 42°C, followed by washing, staining, and scanning using the GeneChip Instrument System, according to the manufacturer's instructions (Affymetrix). Transcriptional signals were analyzed and visualized along the genome coordinate with the In Silico Molecular Cloning program, Array Edition (In Silico Biology). To compensate for the differences in hybridization efficiency of each 25-mer probe on the chip, we divided the hybridization intensities of cDNA synthesized from total RNA by those of total genome DNA. The signal intensities of each experiment were adjusted to confer a signal average of 500 and normalized by MA plot analysis for comparison of MGB874 and wild-type 168 data.17
,18
The average signal intensities of probes in each coding sequence were calculated after removal of the lowest and highest intensities.
| 3. Results and Discussion |
|---|
|
|
|---|
3.1. Multiple-deletion series mutants design
To construct the multiple-deletion series mutants, we initially identified contiguous genome sequences >10 kb that did not code for RNA or essential proteins. In addition, we excluded all known and possible genes involved in primary metabolism to maintain growth in minimum medium, as well as those related to DNA metabolism to avoid genome instability. In total, 74 regions, including prophage, prophage-like, and secondary metabolite-producing sequences, were selected and individually replaced with the tetracycline-resistant gene (tet) by selection on LB plates. As a result, we obtained deletion mutants for 63 regions, totaling up to
2 Mb (Fig. 1A and Supplementary Table S1). However, a number of the deletion mutants did not grow in SMM, and others showed impaired growth, even in liquid LB medium (Supplementary Table S1).
|
3.2. Step-by-step B. subtilis genome reduction
Next, we attempted to construct a reduced genome B. subtilis strain by step-by-step deletions in regions where single deletions did not affect cell growth, applying the upp (encoding uracil-phosphoribosyl-transferase) cassette and 5-fluorouracil (5-FU ) selection20
|
3.3. Exogenous protein productivity in the B. subtilis genome reduction mutants
To assess the productivity of MGB874 cells in terms of exogenous protein secretion, we examined the production of thermostable alkaline cellulase, Egl237,13
50 copies per cell) harboring the respective genes under the control of a constitutive SigA-dependent promoter of Egl237.13
|
3.4. Reprogramming of the transcriptional regulatory network in MGB874 cells
To assess the molecular events underlying these unexpected phenomena, we compared the transcriptome profiles of MGB874 and wild-type 168 cells during growth in 2xL-Mal medium using a custom Affymetrix tiling chip, as described previously,15
|
When nutrients in the culture medium were exhausted, B. subtilis cells entered the transition state, accompanied by various phenomena, such as competence for transformation, secretion of degradative enzymes, and induction of motility through a complex network of global regulators, including ComPA and DegSU two-component systems, the AbrB transition state regulator, and the alternative sigma factor, SigD. Finally, phosphorylation of a two-component regulator, Spo0A, triggers a regulatory program for spore formation involving the activation of an alternative sigma factor, Spo0H, and sporulation-specific sigma factors, SigF and SigG, in prespores and SigE and SigK in mother cells.22
|
Maintenance of metabolic activities in the extended transition state of MGB874 cells would be a basis for increased enzyme productivity. In addition, the remarkable changes in gene expression observed might be related to higher protein productivity of MGB874 cells (Fig. 5F). B. subtilis SigD, activated in the transition state, is responsible for the transcription of genes for flagellar assembly, motility, chemotaxis, and autolysis.26
These results indicate that considerable reprogramming of the transcriptional regulatory network occurs in MGB874 cells, probably due to the synergistic effect of multiple deletions, although the molecular basis for these changes and their relationship to increased protein productivity await further investigation.
| 4. Conclusion |
|---|
|
|
|---|
To our knowledge, this is the first report demonstrating that genome reduction actually contributes to the creation of bacterial cells with a practical application in industry. It is not clear at the moment that phenomena we observed are due to a global synergistic effect of large-scale genome reduction or mainly due to the deletion of several regulators. Further systematic analysis of changes in the transcriptional regulatory network of MGB874 cells in relation to protein productivity should facilitate the generation of improved B. subtilis cells as hosts of industrial protein production. We are in the process of introducing further rational deletions on the basis of transcriptome data, gene function information, and comparative genomics, with a view to generating simple, predictable cells comprising genes with defined functions as a new platform of development of bacterial strains for industrial use.
| Funding |
|---|
|
|
|---|
This work is part of the subproject Development of a Technology for the Creation of a Host Cell included within the industrial technology project Development of Generic Technology for Production Process Starting Productive Function of the Ministry of Economy, Trade and Industry, entrusted by the New Energy and Industrial Technology Development Organization (NEDO), Japan.
| Supplementary Data |
|---|
|
|
|---|
Supplementary data are available online at www.dnaresearch.oxfordjournals.org.
| Acknowledgements |
|---|
|
|
|---|
We are grateful to Shu Ishikawa and Taku Oshima for help in transcriptome analysis and to Junichi Sekiguchi, Kouji Nakamura, and Fujio Kawamura for valuable discussions. This work is part of the subproject Development of a Technology for the Creation of a Host Cell included within the industrial technology project Development of Generic Technology for Production Process Starting Productive Function of the Ministry of Economy, Trade and Industry, entrusted by the New Energy and Industrial Technology Development Organization (NEDO), Japan.
| Footnotes |
|---|
* To whom correspondence should be addressed. Tel. + 81 743-72-5430. Fax. + 81 743-72-5439. E-mail: nogasawa{at}bs.naist.jp
These authors contributed equally to this work. ![]()
| References |
|---|
|
|
|---|
- Ball P. Synthetic biology: designs for life. Nature (2007) 448:32–33.[CrossRef][Medline]
- Drubin D. A., Way J. C., Silver P. A. Designing biological systems. Genes Develop. (2007) 21:242–254.
[Abstract/Free Full Text] - Forster A. C., Church G. M. Synthetic biology projects in vitro. Genome Res (2007) 17:1–6.
[Abstract/Free Full Text] - Posfai G., Plunkett G. III, Feher T., Frisch D., Keil G. M., Umenhoffer K., Kolisnychenko V., Stahl B., Sharma S. S., de Arruda M., et al. Emergent properties of reduced-genome Escherichia coli. Science (2006) 312:1044–1046.
[Abstract/Free Full Text] - Mizoguchi H., Mori H., Fujio T. Escherichia coli minimum genome factory. Biotechnol. Appl. Biochem. (2007) 46:157–167.[CrossRef][Web of Science]
- Ara K., Ozaki K., Nakamura K., Yamane K., Sekiguchi J., Ogasawara N. Bacillus minimum genome factory: effective utilization of microbial genome information. Biotechnol. Appl. Biochem. (2007) 46:169–178.[CrossRef][Web of Science]
- Westers H., Dorenbos R., van Dijl J. M., Kabel J., Flanagan T., Devine K. M., Jude F., Seror S. J., Beekman A. C., Darmon E., et al. Genome engineering reveals large dispensable regions in Bacillus subtilis. Mol. Biol. Evol. (2003) 20:2076–2090.
[Abstract/Free Full Text] - Westers L., Westers H., Quax W. J. Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. Biochim. Biophys. Acta (2004) 1694:299–310.[Medline]
- Kunst F., Ogasawara N., Moszer I., Albertini A. M., Alloni G., Azevedo V., Bertero M. G., Bessieres P., Bolotin A., Borchert S., et al. The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 390:249–256.[CrossRef][Medline]
- Kobayashi K., Ehrlich S. D., Albertini A., Amati G., Andersen K. K., Arnaud M., Asai K., Ashikaga S., Aymerich S., Bessieres P., et al. Essential Bacillus subtilis genes. Proc. Natl. Acad. Sci. USA (2003) 100:4678–4683.
[Abstract/Free Full Text] - Anagnostopoulos C., Spizizen J. Requirements for transformation in Bacillus Subtilis. J. Bacteriol. (1961) 81:741–746.
[Free Full Text] - Harwood C. R., Archibald A. R. Growth, maintenance and general techniques, In. In: Molecular Biological Methods for Bacillus—Harwood C. R., Cutting S. M, eds. (1990) Chichester, New York, Brisbane, Toronto, Singapore: John Wiley & Sons. 549.
- Hakamada Y., Hatada Y., Koike K., Yoshimatsu T., Kawai S., Kobayashi T., Ito S. Deduced amino acid sequence and possible catalytic residues of a thermostable, alkaline cellulase from an Alkaliphilic bacillus strain. Biosci. Biotech. Biochem. (2000) 64:2281–2289.[CrossRef][Medline]
- Kobayashi T., Hakamada Y., Adachi S., Hitomi J., Yoshimatsu T., Koike K., Kawai S., Ito S. Purification and properties of an alkaline protease from alkalophilic Bacillus sp. KSM-K16. Appl. Microbiol. Biotechnol. (1995) 43:473–481.[CrossRef][Web of Science][Medline]
- Ishikawa S., Ogura Y., Yoshimura M., Okumura H., Cho E., Kawai Y., Kurokawa K., Oshima T., Ogasawara N. Distribution of stable DnaA binding sites on the Bacillus subtilis genome detected using a modified ChIP-chip method. DNA Res (2007) 14:155–168.
[Abstract/Free Full Text] - Igo M. M., Losick R. Regulation of a promoter that is utilized by minor forms of RNA polymerase holoenzyme in Bacillus subtilis. J. Mol. Biol. (1986) 191:615–624.[CrossRef][Web of Science][Medline]
- Quackenbush J. Microarray data normalization and transformation. Nature Genet (2002) 32(Suppl):496–501.[CrossRef][Web of Science][Medline]
- Hirai M. Y., Klein M., Fujikawa Y., Yano M., Goodenowe D. B., Yamazaki Y., Kanaya S., Nakamura Y., Kitayama M., Suzuki H., et al. Elucidation of gene-to-gene and metabolite-to-gene networks in Arabidopsis by integration of metabolomics and transcriptomics. J. Biol. Chem. (2005) 280:25590–25595.
[Abstract/Free Full Text] - Itaya M. Construction of a novel tetracycline resistance gene cassette useful as a marker on the Bacillus subtilis chromosome. Biosci. Biotech. Biochem. (1992) 56:685–686.[Medline]
- Fabret C., Ehrlich S. D., Noirot P. A. A new mutation delivery system for genome-scale approaches in Bacillus subtilis. Mol. Microbiol. (2002) 46:25–36.[CrossRef][Web of Science][Medline]
- Hodge J. E., Hofreiter B. T. Analysis and preparation of sugars, In:. In: Methods in Carbohydrate Chemistry—Whistler R. L., Wolfrom M. L, eds. (1962) New York, San Francisco, London: Academic Press. 388–389.
- Piggot P. J., Hilbert D. W. Sporulation of Bacillus subtilis. Curr. Opin. Microbiol. (2004) 7:579–586.[CrossRef][Web of Science][Medline]
- Ogura M., Yamaguchi H., Yoshida K., Fujita Y., Tanaka T. DNA microarray analysis of Bacillus subtilis DegU, ComA and PhoP regulons: an approach to comprehensive analysis of B. subtilis two-component regulatory systems. Nucleic Acids Res. (2001) 29:3804–3813.
[Abstract/Free Full Text] - Hamoen L. W., Van Werkhoven A. F., Venema G., Dubnau D. The pleiotropic response regulator DegU functions as a priming protein in competence development in Bacillus subtilis. Proc. Natl. Acad. Sci. USA (2000) 97:9246–9251.
[Abstract/Free Full Text] - Olmos J., de Anda R., Ferrari E., Bolivar F., Valle F. Effects of the sinR and degU32 (Hy) mutations on the regulation of the aprE gene in Bacillus subtilis. Mol. Gen. Genet. (1997) 253:562–567.[CrossRef][Web of Science][Medline]
- Mirel D. B., Estacio W. F., Mathieu M., Olmsted E., Ramirez J., Marquez-Magana L. M. Environmental regulation of Bacillus subtilis sigma(D)-dependent gene expression. J. Bacteriol. (2000) 182:3055–3062.
[Abstract/Free Full Text] - Serizawa M., Yamamoto H., Yamaguchi H., Fujita Y., Kobayashi K., Ogasawara N., Sekiguchi J. Systematic analysis of SigD-regulated genes in Bacillus subtilis by DNA microarray and northern blotting analyses. Gene (2004) 329:125–136.[CrossRef][Web of Science][Medline]
- Antelmann H., Scharf C., Hecker M. Phosphate starvation-inducible proteins of Bacillus subtilis: proteomics and transcriptional analysis. J. Bacteriol. (2000) 182:4478–4490.
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




